AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
MCV MVAC IN ADVANCED-CARCINOMA OF THE UROTHELIUM/
Authors: EPELBAUM R RUBINOV R KUTEN A IVRY S SKIGIN R HAIM N
Citation: R. Epelbaum et al., MCV MVAC IN ADVANCED-CARCINOMA OF THE UROTHELIUM/, Annals of oncology, 9, 1998, pp. 289-289
MALIGNANT-LYMPHOMA OF BONE
Authors: EPELBAUM R HALBERTAL S BENSHAHAR M KUTEN A SKIGIN R VIZEL B HAIM N
Citation: R. Epelbaum et al., MALIGNANT-LYMPHOMA OF BONE, Annals of oncology, 9, 1998, pp. 535-535
ELEVATED LEVELS OF HAPTOGLOBIN-RELATED PROTEIN IN SERA OF CANCER-PATIENTS
Authors: SHALITIN C VALANSI C ADMON A MOSKOVITZ B SEGAL R EPELBAUM R NATIV O
Citation: C. Shalitin et al., ELEVATED LEVELS OF HAPTOGLOBIN-RELATED PROTEIN IN SERA OF CANCER-PATIENTS, Journal of tumor marker oncology, 13(1), 1998, pp. 15-25
PREDICTION OF OUTCOME OF PATIENTS WITH HODGKINS-DISEASE (HD) BY GA-67SCINTIGRAPHY AFTER ONE CYCLE OF CHEMOTHERAPY
Authors: FRONT D BARSHALOM R MOR M HAIM N EPELBAUM R FRENKEL A GAITINI D KOLODNY GM ISRAEL O
Citation: D. Front et al., PREDICTION OF OUTCOME OF PATIENTS WITH HODGKINS-DISEASE (HD) BY GA-67SCINTIGRAPHY AFTER ONE CYCLE OF CHEMOTHERAPY, The Journal of nuclear medicine, 39(5), 1998, pp. 31-31
PREDICTION OF OUTCOME IN NON-HODGKINS-LYMPHOMA (NHL) PATIENTS USING GA-67 SCINTIGRAPHY EARLY DURING TREATMENT
Authors: FRONT D BARSHALOM R MOR M HAIM N EPELBAUM R FRENKEL A GAITINI D KOLODNY GM ISRAEL O
Citation: D. Front et al., PREDICTION OF OUTCOME IN NON-HODGKINS-LYMPHOMA (NHL) PATIENTS USING GA-67 SCINTIGRAPHY EARLY DURING TREATMENT, The Journal of nuclear medicine, 39(5), 1998, pp. 32-32
TREATMENT OF RELAPSING AND REFRACTORY NON-HODGKINS-LYMPHOMA WITH A COMBINATION OF DEXAMETHASONE, ARA-C, IFOSFAMIDE AND CISPLATIN (DAIP)
Authors: HAIM N BENSHAHAR M LEVIOV M SHKLAR Z OMER A EPELBAUM R
Citation: N. Haim et al., TREATMENT OF RELAPSING AND REFRACTORY NON-HODGKINS-LYMPHOMA WITH A COMBINATION OF DEXAMETHASONE, ARA-C, IFOSFAMIDE AND CISPLATIN (DAIP), European journal of cancer, 33, 1997, pp. 1217-1217
PHASE-II TRIAL OF THE ORAL PLATINUM COMPLEX JM216 IN NON-SMALL-CELL LUNG-CANCER - AN EORTC EARLY CLINICAL-STUDIES GROUP INVESTIGATION
Authors: JUDSON I CERNY T EPELBAUM R DUNLOP D SMYTH J SCHAEFER B ROELVINK M KAPLAN S HANAUSKE A
Citation: I. Judson et al., PHASE-II TRIAL OF THE ORAL PLATINUM COMPLEX JM216 IN NON-SMALL-CELL LUNG-CANCER - AN EORTC EARLY CLINICAL-STUDIES GROUP INVESTIGATION, Annals of oncology, 8(6), 1997, pp. 604-606
GA-67 SCINTIGRAPHY FOR DIAGNOSIS OF TUMOR PROGRESSION DURING TREATMENT OF LYMPHOMA
Authors: FRONT D BARSHALOM R HAIM N EPELBAUM R FRENKEL A GAITINI D HERMONI N KOLODNY GM ISRAEL O
Citation: D. Front et al., GA-67 SCINTIGRAPHY FOR DIAGNOSIS OF TUMOR PROGRESSION DURING TREATMENT OF LYMPHOMA, The Journal of nuclear medicine, 38(5), 1997, pp. 430-430
BENIGN PROLIFERATIVE LESIONS MIMICKING RECURRENCE OF HODGKINS-DISEASE
Authors: EPELBAUM R BENARIE Y BARSHALOM R GAITINI D BENSHAHAR M LEVIOV M BENHAIM S ISRAEL O FRONT D HAIM N
Citation: R. Epelbaum et al., BENIGN PROLIFERATIVE LESIONS MIMICKING RECURRENCE OF HODGKINS-DISEASE, Medical and pediatric oncology, 28(3), 1997, pp. 187-190
DEXAMETHASONE, ETOPOSIDE, IFOSFAMIDE, AND CISPLATIN AS 2ND-LINE THERAPY IN PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA
Authors: HAIM N BENSHAHAR M FARAGGI D TSURIETZIONI A LEVIOV M EPELBAUM R
Citation: N. Haim et al., DEXAMETHASONE, ETOPOSIDE, IFOSFAMIDE, AND CISPLATIN AS 2ND-LINE THERAPY IN PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA, Cancer, 80(10), 1997, pp. 1989-1996
FAMILIAL INCIDENCE OF LYMPHOMA - A POPULATION-BASED STUDY
Authors: PALTIEL O SHMIT T POLLIACK A COHEN A ADLER B HAIM N BENSHACHAR M BARCHANA M EPELBAUM R RACHMILEWITZ EA BENYEHUDA D
Citation: O. Paltiel et al., FAMILIAL INCIDENCE OF LYMPHOMA - A POPULATION-BASED STUDY, Blood, 90(10), 1997, pp. 3934-3934
CLINICAL CHARACTERISTICS OF NON-HODGKINS-LYMPHOMA AS A 2ND PRIMARY TUMOR - A POPULATION-BASED SURVEY
Authors: ROBINSON E BARDEROMA R EPELBAUM R RENNERT G NEUGUT AI
Citation: E. Robinson et al., CLINICAL CHARACTERISTICS OF NON-HODGKINS-LYMPHOMA AS A 2ND PRIMARY TUMOR - A POPULATION-BASED SURVEY, Leukemia & lymphoma, 20(3-4), 1996, pp. 297-301
EO9 PHASE-II STUDY IN ADVANCED BREAST, GASTRIC, PANCREATIC AND COLORECTAL-CARCINOMA BY THE EORTC EARLY CLINICAL-STUDIES GROUP
Authors: DIRIX LY TONNESEN F CASSIDY J EPELBAUM R HUININK WWT PAVLIDIS N SORIO R GAMUCCI T WOLFF I TEVELDE A LAN J VERWEIJ J
Citation: Ly. Dirix et al., EO9 PHASE-II STUDY IN ADVANCED BREAST, GASTRIC, PANCREATIC AND COLORECTAL-CARCINOMA BY THE EORTC EARLY CLINICAL-STUDIES GROUP, European journal of cancer, 32A(11), 1996, pp. 2019-2022
PREVENTION OF IRREVERSIBLE CHEMOTHERAPY-INDUCED OVARIAN DAMAGE IN YOUNG-WOMEN WITH LYMPHOMA BY A GONADOTROPIN-RELEASING-HORMONE AGONIST IN PARALLEL TO CHEMOTHERAPY
Authors: BLUMENFELD Z AVIVI I LINN S EPELBAUM R BENSHAHAR M HAIM N
Citation: Z. Blumenfeld et al., PREVENTION OF IRREVERSIBLE CHEMOTHERAPY-INDUCED OVARIAN DAMAGE IN YOUNG-WOMEN WITH LYMPHOMA BY A GONADOTROPIN-RELEASING-HORMONE AGONIST IN PARALLEL TO CHEMOTHERAPY, Human reproduction, 11(8), 1996, pp. 1620-1626
DIFFUSE LUNG UPTAKE OF GA-67 AFTER TREATMENT OF LYMPHOMA - IS IT OF CLINICAL IMPORTANCE
Authors: BARSHALOM R ISRAEL O HAIM N LEVIOV M EPELBAUM R FRENKEL A BENHAIM S KOLODNY GM FRONT D
Citation: R. Barshalom et al., DIFFUSE LUNG UPTAKE OF GA-67 AFTER TREATMENT OF LYMPHOMA - IS IT OF CLINICAL IMPORTANCE, Radiology, 199(2), 1996, pp. 473-476
INTERMEDIATE AND HIGH-GRADE GASTRIC NON-HODGKINS-LYMPHOMA - A PROSPECTIVE-STUDY OF NONSURGICAL TREATMENT WITH PRIMARY CHEMOTHERAPY, WITH ORWITHOUT RADIOTHERAPY
Authors: HAIM N LEVIOV M BENARIEH Y EPELBAUM R FREIDIN N RESHEF R BENSHAHAR M
Citation: N. Haim et al., INTERMEDIATE AND HIGH-GRADE GASTRIC NON-HODGKINS-LYMPHOMA - A PROSPECTIVE-STUDY OF NONSURGICAL TREATMENT WITH PRIMARY CHEMOTHERAPY, WITH ORWITHOUT RADIOTHERAPY, Leukemia & lymphoma, 17(3-4), 1995, pp. 321-326
DEXAMETHASONE, ETOPOSIDE, IFOSFAMIDE END CISPLATIN AS 2ND-LINE CHEMOTHERAPY IN INTERMEDIATE OR HIGH-GRADE NON-HODGKINS-LYMPHOMA
Authors: HAIM N BENSHAHAR M EPELBAUM R ROBINSON E
Citation: N. Haim et al., DEXAMETHASONE, ETOPOSIDE, IFOSFAMIDE END CISPLATIN AS 2ND-LINE CHEMOTHERAPY IN INTERMEDIATE OR HIGH-GRADE NON-HODGKINS-LYMPHOMA, European journal of cancer, 31A, 1995, pp. 810-810
SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY QUANTITATION OF GALLIUM CITRATE UPTAKE FOR THE DIFFERENTIATION OF LYMPHOMA FROM BENIGN HILAR UPTAKE
Authors: EVENSAPIR E BARSHALOM R ISRAEL O FRENKEL A IOSILEVSKY G HAIM N EPELBAUM R GAITINI D KOLODNY GM FRONT D
Citation: E. Evensapir et al., SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY QUANTITATION OF GALLIUM CITRATE UPTAKE FOR THE DIFFERENTIATION OF LYMPHOMA FROM BENIGN HILAR UPTAKE, Journal of clinical oncology, 13(4), 1995, pp. 942-946
PROLONGED DAILY ADMINISTRATION OF ORAL ETOPOSIDE IN LYMPHOMA FOLLOWING PRIOR THERAPY WITH ADRIAMYCIN, AN IFOSFAMIDE-CONTAINING SALVAGE COMBINATION, AND INTRAVENOUS ETOPOSIDE
Authors: HAIM N BENSHAHAR M EPELBAUM R
Citation: N. Haim et al., PROLONGED DAILY ADMINISTRATION OF ORAL ETOPOSIDE IN LYMPHOMA FOLLOWING PRIOR THERAPY WITH ADRIAMYCIN, AN IFOSFAMIDE-CONTAINING SALVAGE COMBINATION, AND INTRAVENOUS ETOPOSIDE, Cancer chemotherapy and pharmacology, 36(4), 1995, pp. 352-355
FULL DOSE CHOP CHEMOTHERAPY IN ELDERLY PATIENTS WITH NON-HODGKINS-LYMPHOMA
Authors: EPELBAUM R HAIM N LEVIOV M BENSHAHAR M BENARIE Y DROR Y FARAGGI D
Citation: R. Epelbaum et al., FULL DOSE CHOP CHEMOTHERAPY IN ELDERLY PATIENTS WITH NON-HODGKINS-LYMPHOMA, Acta oncologica, 34(1), 1995, pp. 87-91
LIVER INVOLVEMENT IN LYMPHOMA - ROLE OF GA-67 SCINTIGRAPHY
Authors: BENHAIM S BARSHALOM R ISRAEL O GAITINI D HAIM N EPELBAUM R EVENSAPIR E JERUSHALMI J GIPS S KOLODNY GM FRONT D
Citation: S. Benhaim et al., LIVER INVOLVEMENT IN LYMPHOMA - ROLE OF GA-67 SCINTIGRAPHY, The Journal of nuclear medicine, 36(5), 1995, pp. 900-904
GA-67 SCINTIGRAPHY IN LYMPHOMA WITH BONE INVOLVEMENT
Authors: BARSHALOM R ISRAEL O EPELBAUM R HAIM N BENARUSH M BENSHACHAR M LEVIOV M GAITINI D BENHAIM S EVENSAPIR E KOLODNY GM FRONT D
Citation: R. Barshalom et al., GA-67 SCINTIGRAPHY IN LYMPHOMA WITH BONE INVOLVEMENT, The Journal of nuclear medicine, 36(3), 1995, pp. 446-450
LOW-GRADE LYMPHOMA IS NOT GALLIUM AVID - FACT OR MYTH
Authors: BENHAIM S BARSHALOM R ISRAEL O HAIM N EPELBAUM R FRONT D
Citation: S. Benhaim et al., LOW-GRADE LYMPHOMA IS NOT GALLIUM AVID - FACT OR MYTH, Radiology, 197, 1995, pp. 319-319
INCREASED LEVELS OF A 21-KDA PROTEIN IN THE CIRCULATION OF TUMOR-BEARING PATIENTS
Authors: SHALITIN C EPELBAUM R MOSKOVITZ B SEGAL R VALANSI C WERNER M LIVNE PM
Citation: C. Shalitin et al., INCREASED LEVELS OF A 21-KDA PROTEIN IN THE CIRCULATION OF TUMOR-BEARING PATIENTS, Cancer detection and prevention, 18(5), 1994, pp. 357-365
GA-67 UPTAKE IN A MASS OF BENIGN TRANSFORMATION MIMICKING RECURRENCE OF NODULAR LYMPHOCYTIC PREDOMINANCE HODGKINS-DISEASE
Authors: BARSHALOM R BENARIE Y GAITINI D EPELBAUM R PARMETT S ISRAEL O FRONT D
Citation: R. Barshalom et al., GA-67 UPTAKE IN A MASS OF BENIGN TRANSFORMATION MIMICKING RECURRENCE OF NODULAR LYMPHOCYTIC PREDOMINANCE HODGKINS-DISEASE, The Journal of nuclear medicine, 35(3), 1994, pp. 465-468
Risultati: 1-25 | 26-28